Last reviewed · How we verify

Cefadroxil tablets manufactured by NP

GlaxoSmithKline · FDA-approved active Small molecule

Cefadroxil tablets manufactured by NP is a First-generation cephalosporin Small molecule drug developed by GlaxoSmithKline. It is currently FDA-approved for Urinary tract infections, Skin and soft tissue infections, Respiratory tract infections.

Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands.

Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands. Used for Urinary tract infections, Skin and soft tissue infections, Respiratory tract infections.

At a glance

Generic nameCefadroxil tablets manufactured by NP
SponsorGlaxoSmithKline
Drug classFirst-generation cephalosporin
TargetPenicillin-binding proteins (PBPs)
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

Cefadroxil works by disrupting the formation of the bacterial cell wall, which is essential for bacterial survival and structural integrity. By inhibiting cross-linking of peptidoglycan, the drug causes cell wall weakening and bacterial lysis. This bactericidal mechanism is effective against a broad spectrum of gram-positive and some gram-negative bacteria.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Cefadroxil tablets manufactured by NP

What is Cefadroxil tablets manufactured by NP?

Cefadroxil tablets manufactured by NP is a First-generation cephalosporin drug developed by GlaxoSmithKline, indicated for Urinary tract infections, Skin and soft tissue infections, Respiratory tract infections.

How does Cefadroxil tablets manufactured by NP work?

Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands.

What is Cefadroxil tablets manufactured by NP used for?

Cefadroxil tablets manufactured by NP is indicated for Urinary tract infections, Skin and soft tissue infections, Respiratory tract infections, Streptococcal pharyngitis.

Who makes Cefadroxil tablets manufactured by NP?

Cefadroxil tablets manufactured by NP is developed and marketed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

What drug class is Cefadroxil tablets manufactured by NP in?

Cefadroxil tablets manufactured by NP belongs to the First-generation cephalosporin class. See all First-generation cephalosporin drugs at /class/first-generation-cephalosporin.

What development phase is Cefadroxil tablets manufactured by NP in?

Cefadroxil tablets manufactured by NP is FDA-approved (marketed).

What are the side effects of Cefadroxil tablets manufactured by NP?

Common side effects of Cefadroxil tablets manufactured by NP include Diarrhea, Nausea, Vomiting, Rash, Hypersensitivity reactions.

What does Cefadroxil tablets manufactured by NP target?

Cefadroxil tablets manufactured by NP targets Penicillin-binding proteins (PBPs) and is a First-generation cephalosporin.

Related